European Medicines Agency (EMA)

It is important to engage with the regulatory process at European level, and Alex was involved in an exon skipping workshop to engage all stakeholders at the EMA. A paper will shortly be published on the outcomes of the meeting.

Published on 12 December 2016

Share this article
Categories Uncategorised